The China International Import Expo (CIIE), a wonderful platform to showcase the most innovative technologies and solutions the UK has to offer, has witnessed British enterprises flocking in since its first edition, John Edwards, the British Trade commissioner for China, said in an interview during its fourth edition in 2021.

The Medical Equipment and Healthcare Products exhibition area at the CIIE has become an important platform for global pharmaceutical enterprises to explore the Chinese market and share development opportunities in China.

Last year, nearly 350 companies from 33 countries and regions joined the area at the fourth CIIE. Among them were more than 70 Fortune Global 500 companies in the medical and pharmaceutical industry occupying a combined exhibition area of 70,000 square meters.

Multinational pharmaceutical companies such as AstraZeneca, Novartis, MSD, Sanofi, and GSK stepped onstage to bring the latest products, technologies, and services to the massive market.

The exhibition area featured 135 technology and product debuts, more than all the others last year.

The strong demand for medical products in the local market is the fundamental reason for suppliers to choose the Chinese market.

At the fourth CIIE, pharmaceutical enterprises such as Novartis, Bayer, Sanofi, and Stryker signed cooperation agreements with several procurement offices led by the National Healthcare Security Administration. A deal worth more than 47 billion yuan ($6.79 billion)
of imported drugs and medical consumables was reached.

Apart from the centralized procurement of medicine and medical equipment, the CIIE is the platform where worldwide companies are able to connect with Chinese domestic buyers.

In a recent pre-expo matchmaking meeting, more than 30 exhibitors from the Medical Equipment and Healthcare Products Exhibition Area, including Medtronic, Johnson & Johnson, and Roche Diagnostics, found their potential buyers and established business ties.

Bringing its top product Micra AV, an upgraded edition of the world’s smallest leadless cardiac pacemaker, Medtronic shared the story of the landing result that went far beyond expectation.

“We launched the first generation of the pacemaker Micra back at the first CIIE and it hit the market at the second CIIE. During the third CIIE, we brought the upgraded version called Micra AV, which came into the market at the beginning of this year,” said Xu Yanfeng, associate director of external communications at Medtronic during the matchmaking meeting.

“Until now, we have seen nearly 6,000 cases of applications, which is gratifying,” Xu added.

Buoyed by the positive impact of taking part in the CIIE, US-based supplier of radiation cancer treatment Varian Medical Systems established its global innovation center in Beijing to better serve the demands in the Chinese market and this center is expected to go into operation within this year.

“Our participation in the CIIE over the past editions has reinforced our confidence in the Chinese market,” said Zhang Xiao, Varian’s vice-president and head of Varian Greater China.

As scheduled, the fifth CIIE will be held from Nov 5 to 10.

The rehab and elderly care subsection will return to the Medical Equipment & Healthcare Products exhibition area. The subsection, which is expected to occupy 4,000 sq m this year, has attracted many major companies, including Sivantos Group, a hearing aid manufacturer, Bewatec, a German supplier of hardware and software solutions for hospitals, and Ossur, an Iceland-based producer of non-invasive equipment for orthopedics.

Be sure to browse the official website of the CIIE for more information about the upcoming 5th edition:

Contact:Ms. Cui Yan


Email:[email protected]